Speaker Profile

M.D., Ph.D., CEO, Immix Biopharma Inc.

Dr. Ilya Rachman is a physician-scientist and clinical faculty at UCLA. He received both his MD and PhD in neuroscience and cell biology from the University of Illinois-Chicago, and his MBA from UCLA Anderson. Previous to Immix, Dr. Rachman founded a clinical research organization that conducted clinical trials on behalf of pharmaceutical companies. He has completed several clinical trials as a Principal Investigator and is a co-inventor of Immix’ platform therapeutic technology.

Immunotherapy Showcase: Immix Biopharma Inc
Immix Biopharma Inc develops novel therapies for cancer patients. The team’s approach is to treat cancer as a progressive de-differentiation towards unicellularity and to shut down the immune system’s support that sustains it.

Don't Miss Important Precision Medicine Updates

PMWC is the most comprehensive precision medicine conference. To receive the lastest news and updates from the field, subscribe to the newsletter here.

View the top 3 talks from PMWC here (password: top-videos).